Uveitis is characterized by intraocular inflammation involving the uveal tract; its etiologies
generally fall into two broad categories: autoimmune/inflammatory or infectious …

Background Non-infectious intermediate uveitis, posterior uveitis and panuveitis are a
heterogeneous group of inflammatory eye disorders. Management includes local and …

A multi-drug delivery platform is developed to address current shortcomings of post-
operative ocular drug delivery. The sustained biodegradable drug release system is …

Anti‐tumour necrosis factor (TNF) drugs have been extensively used in non‐infectious
uveitis (NIU), when corticosteroids or conventional immunosuppressive drugs cannot …

The mainstay of treatment for noninfectious uveitis (NIU) is immunosuppressant therapy.
This may come in a localized form that is administered specifically to the eye or a systemic …

Introduction: Striking recent advance has occurred in the field of medical retina, greatly
because intraocular drugs have been developed, enhancing their clinical efficacy while …

Intermediate uveitis is a major anatomic category of uveitis with predominantly vitreous
inflammation [1]. Systemic illnesses such as sarcoidosis and MS may be present, and …

A 41-year-old man reported visual obscuration in his left eye of 2 weeks' duration after a
history of a fluocinolone acetonide intravitrealimplant5yearsagoforintermediate …

Uveitis is a heterogenous group of disorders defined by intraocular inflammation and
accounts for an estimated 10% of legal blindness in the United States. 1–4 Most cases of …

Methods: The patient's surgery was video recorded, and the medical notes were reviewed
retrospectively. Results: A patient developed a macula off retinal detachment over 1 year …